Investors Alert: INSYS Therapeutics (NASDAQ:INSY), Johnson & Johnson (NYSE:JNJ), Barnes & Noble (NYSE:BKS), UBS Group AG (NYSE:UBS), Envestnet (NYSE:ENV)

On Monday shares of INSYS Therapeutics, Inc. (NASDAQ:INSY) closed at $59.68. Company’s EPS growth for next 5 years is recorded as 28.00%. Zacks upgraded shares of Insys Therapeutics (NASDAQ:INSY) from a hold rating to a strong-buy rating in a report issued on Friday. They currently have $68.00 target price on the stock.

Johnson & Johnson (NYSE:JNJ) in last trading activity moved up 1.09% to close at $103.42. Company weekly performance is 2.37% while its quarterly performance stands at 3.69%. Johnson & Johnson (NYSE:JNJ) is -4.45% away from its 52 week high. Hundreds gathered Thursday night at Cipriani 42nd Street in New York to recognize those who have supported Operation Smile, the world’s largest medical charity of its kind providing free cleft surgery and care. Johnson & Johnson (NYSE:JNJ) committed $25 million in financial and product contributions to Operation Smile over the next five years, an extension of the relationship that first began in 1988. Johnson & Johnson Chairman and CEO Alex Gorsky made the announcement at Operation Smile’s 13th annual Smile Event, where the global healthcare company was honored for its long-standing support of the children’s charity.
On Monday shares of Barnes & Noble, Inc. (NYSE:BKS) closed at $22.11. Company’s sales growth for last 5 years was 4.50% and EPS growth for next 5 years is recorded as 10.00%. Barnes & Noble Inc. (NYSE:BKS) announced that Samsung Galaxy Tab 4 NOOK 7-inch version now costs $149.99, while the 10-inch device is available at just $279.99, both in its stores nationwide and online. Barnes & Noble Members are eligible for an additional 10% off both devices.

UBS Group AG (NYSE:UBS) in last trading activity decreased -0.19% to close at $21.19. Company quarterly performance stands at 25.06%. UBS Group AG (NYSE:UBS) is -0.70% away from its 52 week high. UBS Group AG (NYSE:UBS) and the New York Stock Exchange announced a new strategic relationship whereby UBS customers can connect to NYSE Bonds through the UBS Bond Port (formerly named UBS PIN-FI) to access a centralized pool of corporate bond liquidity.

On last trading day Envestnet, Inc. (NYSE:ENV) moved up 0.25% to close at $44.20. Its volatility for the week is 2.81% while volatility for the month is 3.47%. ENV’s sales growth for past 5 years was 35.00% and its EPS growth for past 5 years was 38.90%. Envestnet, Inc. (NYSE:ENV) monthly performance is -16.60%. Envestnet, Inc. (NYSE:ENV), announced that the Company will be attending Brokerage Conference at Le Parker Meridien in New York, NY. On Wednesday, June 3, 2015 the Company will be presenting at the Sandler O’Neill Global Exchange , the presentation will begin at 11:30 AM ET.

Stocks in Focus: Tobira Therapeutics (NASDAQ:TBRA), PTC Therapeutics (NASDAQ:PTCT), Johnson & Johnson (NYSE:JNJ), Dex Media (NASDAQ:DXM), Stemline Therapeutics (NASDAQ:STML)

On Monday shares of Tobira Therapeutics, Inc. (NASDAQ:TBRA) closed at $13.97. Tobira Therapeutics, Inc. (NASDAQ:TBRA) announced on 4 May, the completion of its merger with Regado Biosciences, Inc. (NASDAQ: RGDO, through May 4). In conjunction with the closing of the merger, Tobira raised $40 million of common stock from a combination of new investors and all current Tobira institutional investors, including the previously announced $13 million in debt that converted to common stock in this closing.

PTC Therapeutics, Inc. (NASDAQ:PTCT) in last trading activity decreased -0.19% to close at $51.99. Company weekly performance is -5.28% while its quarterly performance stands at -3.42%. PTC Therapeutics, Inc. (NASDAQ:PTCT) is -33.96% away from its 52 week high. PTC Therapeutics, Inc. (NASDAQ:PTCT) on 11 May, announced it has launched STRIVE (Strategies to Realize Innovation, Vision and Empowerment), an awards program aimed at providing funds to patient advocacy organizations to develop unique and collaborative programs that will make meaningful contributions to the rare disease community by increasing awareness, diagnosis, education or fostering development of future patient advocates.

On Monday shares of Johnson & Johnson (NYSE:JNJ) closed at $103.42. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca (NYSE:AZN), Johnson & Johnson (NYSE:JNJ) and Eli Lilly in partnership with Boehringer Ingleheim may cause dangerously high levels of blood acids that could require hospitalization. The oral drugs belong to a class known as SGLT2 inhibitors that work by causing blood sugar to be secreted in the urine.

Dex Media, Inc. (NASDAQ:DXM) has 0.70% insider ownership while its institutional ownership stands at 75.00%. In last trading activity company’s stock closed at $1.12. On 8 May, Dex Media Inc (NASDAQ:DXM) declared the launch of its new customer relationship administration platform, DexLnk.

On last trading day Stemline Therapeutics, Inc. (NASDAQ:STML) decreased -0.07% to close at $13.42. Its volatility for the week is 4.88% while volatility for the month is 5.36%. STML’s EPS growth for past 5 years was -16.90%. Stemline Therapeutics, Inc. (NASDAQ:STML) monthly performance is -16.70%. On 14 May, Stemline Therapeutics, Inc. (NASDAQ:STML), announced that Ivan Bergstein, M.D., Stemline’s CEO, will present at the UBS Global Healthcare Conference on Monday, May 18, 2015 at 2:30 PM ET.

Top News: Bellicum Pharmaceuticals (NASDAQ:BLCM), Acasti Pharma Inc. (NASDAQ:ACST), First Financial Corp. (NASDAQ:THFF), Johnson & Johnson (NYSE:JNJ), International Business Machines (NYSE:IBM)

On Friday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.02. Bellicum Pharma (NASDAQ:BLCM) announced that clinical results from a study conducted by the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist using the Company’s Caspase-9 safety switch (CaspaCIDe), were simultaneously published in BLOOD and featured today in a late-breaking oral presentation of the American Society of Gene and Cell Therapy (ASGCT) 18th Annual Meeting in New Orleans.

Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity advanced 0.61% to close at $0.38. Company weekly performance is -6.76% while its quarterly performance stands at -13.11%. Acasti Pharma Inc. (NASDAQ:ACST) is -68.66% away from its 52 week high. It was reported on 11 May, that Acasti Pharma Inc. (NASDAQ:ACST) has now been given an additional 180 calendar days, until November 2, 2015, to regain compliance with the minimum $1.00 per share requirement for continued listing on the NASDAQ.

On last trading day First Financial Corp. (NASDAQ:THFF) decreased -0.71% to close at $33.78. Its volatility for the week is 1.85% while volatility for the month is 1.78%. THFF’s sales growth for past 5 years was -2.10% and its EPS growth for past 5 years was 8.10%. First Financial Corp. (NASDAQ:THFF) monthly performance is -3.90%. Zacks upgraded shares of First Financial Corp (NASDAQ:THFF) from a sell rating to a hold rating in a research note released on 11 May.

On Friday shares of Johnson & Johnson (NYSE:JNJ) closed at $102.30. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to answer on the same issue.

International Business Machines Corporation (NYSE:IBM) in last trading activity fell -0.45% to close at $173.26. Company weekly performance is 0.34% while its quarterly performance stands at 8.83%. International Business Machines Corporation (NYSE:IBM) is -9.35% away from its 52 week high. International Business Machines Corporation (NYSE:IBM) has announced new servers, and storage software and solutions that it said would help more clients create hybrid cloud computing environments.

Morning Alert: Abbott Laboratories (NYSE:ABT), SeaDrill Limited (NYSE:SDRL), Pioneer Natural Resources Co. (NYSE:PXD), Johnson & Johnson (NYSE:JNJ), Heritage-Crystal Clean, Inc (NASDAQ:HCCI)

On Thursday shares of Abbott Laboratories (NYSE:ABT) closed at $48.67. Company’s sales growth for last 5 years was -8.00% and EPS growth for next 5 years is recorded as 9.70%. Abbott Laboratories (NYSE:ABT) Effective June 1, 2015,Thomas C. Freyman has been appointed Executive Vice President, Finance and Administration; John M. Capek has been appointed Executive Vice President, Ventures; and, Brian B. Yoor, has been appointed Senior Vice President, Finance and Chief Financial Officer, and will continue to report to Mr. Freyman in his new role.

SeaDrill Limited (NYSE:SDRL) in last trading activity fell -6.13% to close at $14.08. Company weekly performance is 5.31% while its quarterly performance stands at 8.14%. SeaDrill Limited (NYSE:SDRL) is -64.23% away from its 52 week high. SeaDrill Limited (NYSE:SDRL) has slated to release earnings on May 27.

On last trading day Pioneer Natural Resources Co. (NYSE:PXD) moved up 0.89% to close at $153.24. Its volatility for the week is 3.16% while volatility for the month is 3.00%. PXD’s sales growth for past 5 years was 23.50% and its EPS growth for past 5 years was 49.20%. Pioneer Natural Resources Co. (NYSE:PXD) monthly performance is -14.84%. Pioneer Natural Resources Company (NYSE:PXD) on 5 May, announced financial and operating results for the quarter ended March 31, 2015. Pioneer reported a first quarter net loss attributable to common stockholders of $78 million, or $0.52 per diluted share. Without the effect of noncash derivative mark-to-market gains and other unusual items, adjusted income for the first quarter was a loss of $5 million after tax, or $0.03 per diluted share.

On Thursday shares of Johnson & Johnson (NYSE:JNJ) closed at $101.83. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to answer on the same issue.

On last trading day Heritage-Crystal Clean, Inc (NASDAQ:HCCI) moved up 1.31% to close at $13.16. Its volatility for the week is 5.66% while volatility for the month is 4.18%. HCCI’s sales growth for past 5 years was 28.10% and its EPS growth for past 5 years was -33.50%. Heritage-Crystal Clean, Inc (NASDAQ:HCCI) monthly performance is -3.87%. Heritage-Crystal Clean (NASDAQ:HCCI)‘s stock had its “hold” rating reaffirmed by Zacks in a research note issued on 1 May.

Traders Are Watching: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Johnson & Johnson (NYSE:JNJ), American Express (NYSE:AXP), Rose Rock Midstream (NYSE:RRMS), Extra Space Storage (NYSE:EXR)

On Wednesday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $2.87. On 8 May, CymaBay Therapeutics, Inc. (NASDAQ:CBAY) reported Q1 results. The company said, Net loss for the three months ended March 31, 2015 was $2.3 million compared to $10.1 million for three months ended March 31, 2014. The difference in net loss between these periods was primarily due to a non-cash gain of $4.6 million for the three months ended March 31, 2015 compared to a non-cash loss of $4.8 million for the three months ended March 31, 2014, from the mark to market valuation of CymaBay’s warrant liability.

On Wednesday shares of Johnson & Johnson (NYSE:JNJ) closed at $100.55. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to answer on the same issue.

On last trading day American Express Company (NYSE:AXP) advanced 0.99% to close at $79.86. Its volatility for the week is 1.27% while volatility for the month is 1.24%. AXP’s sales growth for past 5 years was 6.20% and its EPS growth for past 5 years was 29.40%. American Express Company (NYSE:AXP) monthly performance is 0.47%. American Express Co (NYSE:AXP) approved the repurchase of up to 150 million common shares, from time to time, subject to market conditions and the Federal Reserve’s non-objection of the company’s capital plans. This authorization replaces the prior 150 million share repurchase program that had approximately 45 million shares of common stock remaining under board authorization.

Rose Rock Midstream, L.P. (NYSE:RRMS) has 0.30% insider ownership while its institutional ownership stands at 32.10%. In last trading activity company’s stock closed at $50.81. Rose Rock Midstream LP (NYSE:RRMS) said May 11 it has priced its offering of senior unsecured notes due 2023. The offering was increased to $350 million in aggregate principal amount from $300 million. The notes were priced at 98.345% of par to yield 5.875%. Proceeds will be used to repay amounts borrowed under its revolving credit facility and for general partnership purposes.

On last trading day Extra Space Storage Inc. (NYSE:EXR) decreased -0.52% to close at $68.55. Its volatility for the week is 2.76% while volatility for the month is 2.02%. EXR’s sales growth for past 5 years was 18.20% and its EPS growth for past 5 years was 32.10%. Extra Space Storage Inc. (NYSE:EXR) monthly performance is 2.36%. Citigroup Inc. reiterated their neutral rating on shares of Extra Space Storage (NYSE:EXR) in a research note released on 11 May.

Today’s Hot List: Facebook Inc (NASDAQ:FB), Hemispherx Biopharma (NYSEMKT:HEB), Ford Motor Company (NYSE:F), AerCap Holdings N.V. (NYSE:AER), Johnson & Johnson (NYSE:JNJ)

On Tuesday shares of Facebook Inc (NASDAQ:FB) closed at $77.46. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 27.28%. Facebook Inc (NASDAQ:FB) is reportedly testing out a new feature that would allow users to search for and share links directly from within the Facebook mobile app.

Hemispherx Biopharma, Inc. (NYSEMKT:HEB) in last trading activity advanced 3.08% to close at $0.27. Company weekly performance is -0.74% while its quarterly performance stands at 16.52%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) is -33.00% away from its 52 week high. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) said its European subsidiary, Hemispherx Biopharma Europe N.V./S.A., received formal notification from the European Commission approving its Orphan Medicinal Product Application for Ampligen, an experimental therapeutic, to treat Ebola Virus Disease.

On last trading day Ford Motor Company (NYSE:F) moved down -0.58% to close at $15.56. Its volatility for the week is 1.49% while volatility for the month is 1.34%. F’s sales growth for past 5 years was 4.40% and its EPS growth for past 5 years was -1.40%. Ford Motor Company (NYSE:F) monthly performance is -1.03%. Ford Motor Company (NYSE:F) has issued another recall — its second — for its all-new aluminum-bodied F-150 pickup truck.

AerCap Holdings N.V. (NYSE:AER) has 0.40% insider ownership while its institutional ownership stands at 33.80%. In last trading activity company’s stock closed at $48.48. AerCap Holdings NV (NYSE:AER) 104 aircraft transactions executed including the purchase of 17 aircraft with a value of $1.3 billion. Fleet utilization rate of 99.4%; 7.6 year average age of the owned fleet; and average remaining contracted lease term of 5.9 years.

On Tuesday shares of Johnson & Johnson (NYSE:JNJ) closed at $100.47. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) said on 7 May, it has entered into a “first-of-its-kind partnership,” which enlists a third party to review requests made for compassionate use of its investigation medicines.

Stocks in Focus: Johnson & Johnson (NYSE:JNJ), Gilead Sciences Inc. (NASDAQ:GILD), Seadrill Partners LLC (NYSE:SDLP), AFLAC Inc. (NYSE:AFL), WNS (Holdings) Limited (NYSE:WNS)

On Tuesday shares of Johnson & Johnson (NYSE:JNJ) closed at $100.47. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) become the first pharmaceutical company to formally seek advice from outside medical ethicists on “compassionate use” requests, in which desperate patients ask drugmakers to let them take an experimental medication, the company announced on 7 May.

Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity increased 0.79% to close at $105.56. Company weekly performance is 2.50% while its quarterly performance stands at 7.36%. Gilead Sciences Inc. (NASDAQ:GILD) is -9.65% away from its 52 week high. At the Annual Meeting of Stockholders of Gilead Sciences, Inc. (NASDAQ:GILD) held on May 6, 2015, Gilead’s stockholders approved an amendment and restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan and an amendment and restatement of the Gilead Sciences, Inc. International Employee Stock Purchase Plan.

On last trading day Seadrill Partners LLC (NYSE:SDLP) increased 0.88% to close at $14.86. Its volatility for the week is 5.98% while volatility for the month is 4.46%. SDLP’s EPS growth for past 5 years was 183.26%. Seadrill Partners LLC (NYSE:SDLP) monthly performance is 20.47%. Seadrill Partners LLC (NYSE:SDLP) is scheduled to release its first quarter 2015 results on Thursday May 28th, 2015.

AFLAC Inc. (NYSE:AFL) has 0.30% insider ownership while its institutional ownership stands at 68.60%. In last trading activity company’s stock closed at $63.37. Aflac Incorporated (NYSE:AFL) announced that it webcasted presentation at VirtualInvestorConferences.com. Daniel A. Bellware, CPA, senior manager, Investor Relations, presented on May 7, 2015.

On last trading day WNS (Holdings) Limited (NYSE:WNS) increased 2.18% to close at $25.81. Its volatility for the week is 2.15% while volatility for the month is 2.17%. WNS’s sales growth for past 5 years was -1.70% and its EPS growth for past 5 years was 68.90%. WNS (Holdings) Limited (NYSE:WNS) monthly performance is 6.26%.

Morning Watch List: Highpower International (NASDAQ:HPJ), Esperion Therapeutics (NASDAQ:ESPR), Johnson & Johnson (NYSE:JNJ), BioTelemetry (NASDAQ:BEAT), CDI Corp. (NYSE:CDI)

On Friday shares of Highpower International, Inc. (NASDAQ:HPJ) closed at $4.81. Company’s sales growth for last 5 years was 15.90%. Highpower International, Inc. (NASDAQ: HPJ) announced on 1 May, that it has secured a contract to produce a 100KWH energy storage system (ESS) for China Southern Power Grid Co., Ltd. (CSPG). This ESS system is designed to maintain a balance of supply and demand over the south China grid as part of a long-term energy storage project developed by CSPG.

Esperion Therapeutics, Inc. (NASDAQ:ESPR) in last trading activity increased 3.56% to close at $103.54. Company weekly performance is 3.13% while its quarterly performance stands at 74.34%. Esperion Therapeutics, Inc. (NASDAQ:ESPR) is -12.96% away from its 52 week high. Esperion Therapeutics, Inc. (NASDAQ: ESPR), today provided ETC-1002 (bempedoic acid) development program updates and financial results for the first quarter ended March 31, 2015. “Esperion had another truly transformational quarter,” said Tim M. Mayleben, president and chief executive officer of Esperion. “Following the recently announced positive Phase 2b add-on to statin clinical study results of ETC-1002, we are actively preparing to meet with FDA in the third quarter and eager to advance ETC-1002 into Phase 3 development before year end.

On Friday shares of Johnson & Johnson (NYSE:JNJ) closed at $101.47. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE: JNJ) on 7 May, announced a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for compassionate use of its investigational medicines. This new approach will begin as a pilot program focused on a single Janssen investigational medicine and, if successful, will become a model that will be applicable more broadly across Johnson & Johnson.

BioTelemetry, Inc. (NASDAQ:BEAT) has 6.10% insider ownership while its institutional ownership stands at 71.50%. In last trading activity company’s stock closed at $9.36. BioTelemetry Inc. (NASDAQ:BEAT) on 6 May, reported a loss of $69,000 in its first quarter. The Malvern, Pennsylvania-based company said it had a loss of less than 1 cent on a per-share basis. Earnings, adjusted for non-recurring costs, came to 6 cents per share.

On last trading day CDI Corp. (NYSE:CDI) increased 0.74% to close at $13.68. Its volatility for the week is 3.78% while volatility for the month is 3.08%. CDI’s sales growth for past 5 years was 4.90% and its EPS growth for past 5 years was 16.60%. CDI Corp. (NYSE:CDI) monthly performance is -1.23%. CDI Corp. (NYSE: CDI) announced that its Board of Directors has authorized a second quarter 2015 dividend of $0.13 per share. The dividend is payable on June 2, 2015, to holders of record as of the close of business on May 19, 2015.

Stock Highlights: Insmed Incorporated (NASDAQ:INSM), GlobalSCAPE (NYSEMKT:GSB), Johnson & Johnson (NYSE:JNJ), Hi-Crush Partners LP (NYSE:HCLP), TECO Energy (NYSE:TE)

On Thursday shares of Insmed Incorporated (NASDAQ:INSM) closed at $21.70. Insmed Inc. (NASDAQ:INSM) was downgraded by Zacks from a “buy” rating to a “hold” rating in a report released on 1 May.

GlobalSCAPE, Inc. (NYSEMKT:GSB) in last trading activity increased 5.95% to close at $3.38. Company weekly performance is 0.00% while its quarterly performance stands at 42.01%. GlobalSCAPE, Inc. (NYSEMKT:GSB) is -9.39% away from its 52 week high. Globalscape Inc. (NYSEMKT:GSB) on 30 April, said first-quarter revenue was up 20 percent over the same time last year. Revenue for the quarter ending March 31 was $6.9 million, compared to $5.7 million for the first quarter of 2014. Net income for the quarter was $815,000, compared with net income of $534,000 for the first three months of 2014.

On Thursday shares of Johnson & Johnson (NYSE:JNJ) closed at $99.66. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) announced a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for compassionate use of its investigational medicines.

Hi-Crush Partners LP (NYSE:HCLP) has 0.80% insider ownership while its institutional ownership stands at 33.70%. In last trading activity company’s stock closed at $31.27. Hi-Crush Partners LP (NYSE:HCLP) saw first quarter revenues increase by 45% to $102m, compared to $71m the previous year. This is good news for the company, which has been faced with difficult market conditions following low energy prices.

On last trading day TECO Energy, Inc. (NYSE:TE) increased 0.81% to close at $18.71. Its volatility for the week is 1.91% while volatility for the month is 1.81%. TE’s sales growth for past 5 years was -5.00% and its EPS growth for past 5 years was -1.70%. TECO Energy, Inc. (NYSE:TE) monthly performance is -3.80%. TECO Energy Inc. (NYSE:TE) announced first-quarter 2015 operating earnings of 28 cents per share, on par with the Zacks Consensus Estimate. Total revenues in the first quarter were $693 million, up 19.9% from $578 million in the year-ago period. The upside was fueled by the company’s regulated business, which improved 19.8%, while its unregulated operations rose 34.8%.

Stocks in News: J C Penney (NYSE:JCP), Broadwind Energy (NASDAQ:BWEN), Johnson & Johnson (NYSE:JNJ), 1st Century Bancshares (NASDAQ:FCTY), International Business Machines (NYSE:IBM)

On Wednesday shares of J C Penney Company Inc (NYSE:JCP) closed at $8.19. Company’s sales growth for last 5 years was -6.90%. J. C. Penney Company, Inc. (NYSE:JCP) announced that it will release its first quarter 2015 financial results on Wednesday, May 13, at 4:00 p.m. ET. The news release will be followed by a live conference call and webcast conducted by Chief Executive Officer Mike Ullman, President and CEO-Designee Marvin Ellison and Chief Financial Officer Ed Record that will begin at 4:30 p.m. ET.

Broadwind Energy, Inc. (NASDAQ:BWEN) in last trading activity fell -7.04% to close at $3.70. Company weekly performance is -15.14% while its quarterly performance stands at -30.84%. Broadwind Energy, Inc. (NASDAQ:BWEN) is -73.09% away from its 52 week high. Broadwind Energy Inc (NASDAQ:BWEN) on 30 April, posted a net loss of USD 5 million (EUR 4.4m) for the first quarter of 2015, compared to a USD-1-million loss a year earlier. Revenue dropped 13% to USD 51.1 million, reflecting lower wind turbine tower sales as a result of residual production issues in the Abilene tower plant and delayed revenue due to the West Coast port slowdown. Net new orders in the quarter were USD 23.3 million, up from USD 15.8 million a year ago. Total backlog stood at USD 174 million at the end of March, 35% lower than the same time last year.

On Wednesday shares of Johnson & Johnson (NYSE:JNJ) closed at $99.17. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) announced a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for compassionate use of its investigational medicines.

1st Century Bancshares, Inc. (NASDAQ:FCTY) has 16.90% insider ownership while its institutional ownership stands at 21.70%. In last trading activity company’s stock closed at $7.29. 1st Century Bancshares, Inc. (NASDAQ:FCTY) currently carries a Zacks Rank #4 (Sell).

International Business Machines Corporation (NYSE:IBM) in last trading activity fell -1.75% to close at $170.05. Company weekly performance is -2.49% while its quarterly performance stands at 9.10%. International Business Machines Corporation (NYSE:IBM) is -11.69% away from its 52 week high. International Business Machines Corporation (NYSE:IBM) said Facebook will be its first partner at a new ThinkLab that the company is building in San Francisco.